Status:
COMPLETED
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
Lead Sponsor:
Allergan
Conditions:
Retinal Vein Occlusion
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective data review study will evaluate anti-VEGF injections for retinal vein occlusion (RVO) or diabetic macular edema (DME).
Eligibility Criteria
Inclusion
- Macular edema in the study eye due to RVO or DME
- Received an anti-VEGF injection in the study eye on or after June 2010 for RVO and on or after August 2012 for DME
Exclusion
- None
Key Trial Info
Start Date :
August 2 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 4 2014
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT01918371
Start Date
August 2 2013
End Date
September 4 2014
Last Update
April 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Antonio, Texas, United States